Excitement Grows for Immunotherapy in Lung Cancer – Curetoday.com
Curetoday.com |
Excitement Grows for Immunotherapy in Lung Cancer
Curetoday.com Can you discuss your presentation on checkpoint inhibitors in NSCLC? I was asked to speak on first- and second-line immunotherapy in lung cancer, as well as third-line and beyond. I reviewed the various trials that led to the FDA approval of first-line … |
